COMPANY

Oligomerix, Inc

Also known as Oligomerix · 3 sources

Keywords: neurology small molecule

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.5M (SBIR Phase II 4R44AG091987-02, extension, notice Jun 16, 2026). NIH RePORTER 4R44AG091987-02 (Jun 16, 2026)
Evidence (1 event)
- Jun 16, 2026 · NIH RePORTER 4R44AG091987-02
  Organization: OLIGOMERIX, INC; City/State: Bronx, NY; Project number: 4R44AG091987-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-16; FY total cost (award amount): 1499525; Administering IC: National Institute on Aging; Project title: A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 16, 2026 Grant Government grant — SBIR: $1.5M (annual award, as published), announced Jun 16, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Nov 18, 2025 Grant Government grant: $500,000 (total, as published), announced Nov 18, 2025. Source: company's own press page. source ↗
Aug 18, 2025 Grant Government grant — SBIR: $499,879 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NIA. Source: government award database. source ↗

Last 2 years.

Jun 16, 2026 Government grant — SBIR: $1.5M (annual award, as published), announced Jun 16, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Nov 18, 2025 Government grant: $500,000 (total, as published), announced Nov 18, 2025. Source: company's own press page. source ↗
Aug 18, 2025 Government grant — SBIR: $499,879 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NIA. Source: government award database. source ↗